{"ticker": {"uuid": "b4633899-6f85-4269-8b3a-7e0b73c69fbc", "symbol": "MYX", "name": "Mayne Pharma Group Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Medical Distribution"}, "articles": [{"title": "Mayne Pharma Group (ASX:MYX) Rises 3.55%: What's Behind the Pharma Stock's Move?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOS1lwRG92YVp3cEx1cHBWbkZnc1E4emVPaTBfUFFNRnRQR3Joc0lDSkp6cGFqeFhha2ZMSE5GbU13bnVOYnhGRHhvWHRMRWc4RXNLZjhvMnB3V0U2S1pVd2xHT2FXNzczWGczZy1zeDZTd1BKWklQQ2pmbXUydWJVR1BsaDVuY2JWYTJDMHlKcldfMlRMOTlzNDl6ZHVpR3h5UzdLYVpyQ0F4X25hTGxz?oc=5", "source_name": "Kalkine", "published_at": "2026-07-16T10:30:00+00:00", "published_display": "16 Jul 2026 10:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Private equity kicked the tyres at Mayne\u2019s Adelaide plant, but no dice", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOa1RjZnZ5VkxvQ2FydmVkMVVFSEdFOUtfUUFTWkktdUZQeUxzQlpiMkR1YWl6bEJqNXlIUm1aYllYMUlVRHlyWWVqcm5zbjR3b0Z2b2JYMlJyV0lSV0JOcVpiTHdNSVFqZ2xHckNVSkVSM2pjTVp2dmdKdlNXR1FNemlWSmYyTE93NzZMdmRHX3JQZmlaOFFFRG1qblBaRlVlN05CbnpReHdneXdpNkVLdGVQbXM3UHVD?oc=5", "source_name": "AFR", "published_at": "2026-07-12T05:36:00+00:00", "published_display": "12 Jul 2026 05:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What\u2019s Driving Fresh Interest in Mayne Pharma (ASX:MYX) Shares?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPbVk4ZWtSZVFsWHlRaFFRZ3JKem0zY1U1OGxoQXlERXRLeHA3V01kRm1LVkxaUXB5WldrUmU1Sm80QnRiN3hyUng3cEQ0Q2JSUm1RZTM1N1ZuMVZlcktpZG1HRzY5MWx0QkkteWNELXJLaDc2bk00bTdKWHlYRVQ3dmpEaXpNWTZtM1JJUWZoUFA3WDg2MEdHclZIR1Bvdw?oc=5", "source_name": "Kalkine", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New South Wales Supreme Court Awards Mayne Pharma Group Over AU$13 Million in Legal Costs Following Cosette Pharmaceuticals Proceedings; Shares Up 6%", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxObXlKT1J0czBjYjZ6cE43UEJQQ3ZpYVpkSmlxZTlGUFZEUlN2NFNHWU1QMWVoel9pVzB4S3dNU1pIajlIaFZDQmdxcDZlWWk2MUlUWHlNVXpzdHNrZnZGZXBvTDYwTlQybm5IVTd5N1ZxM3pybVROMzY4M0lxMnNaeXJaWlByTk1oM3pYTHpuQ3dOTDM2R0toZDlEVUItdWI2enNnUQ?oc=5", "source_name": "Moomoo", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mayne Pharma Group (ASX:MYX) Shares Under Pressure as Deep Losses Continue to Weigh on Sentiment", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOa2JFOVZfa2pNLWs1c1E5VWtaNjBfNHVpLUIyblN4UU9veHdPR04zb0wwQTBEVzVUNVFTREk0WHZRMENDbzV4YkxaN2Rab2N0UlFDeWFkRk0zNlFfQVlITFdycmdDU194X0NWb2xsTkMwVVpCLThpTGxjdHp0YWtEMzRTZTVvc28zaXVRSmJ4ZDdCd1Z2Ykh6UlBrTlBrNVRUUlQ2Q3BoWExzaGpRc3Fhdk1Cc3FRaWtXWWUyR0tyenU5MGFhRnZneFRyc0Y?oc=5", "source_name": "Kalkine", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Health Check: We will duck Donald\u2019s tariffs, say CSL and Mayne Pharma", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPZEN0SHNMcnBMemRGUk5Jb2RGa1JUNEtxeTE5RXIySlYxd3B2Q1hqOGtCbE5tbnJjV3p2bDZMeUtIbmFjLThzNXQyd2dwZXB6Njh0cW11dmJ3SnVNYV9HWHZIVTh2clBmX3JZdGdobHc5dGhJa1JjVjlCeGxUWHR2Z01tVVZodFFmZUx0a1ZWT2NmakJ4R0pUaE9pdnJrcmJvUUE?oc=5", "source_name": "Stockhead", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mayne Pharma Group (ASX:MYX) Faces Selling Pressure: What to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxORERFMElIUF9ISTg1bWJaOVBLYmpucTdvVDRYWllSbThsWUpXYVBZazRZSURaTFJFbW1KVkNJbXdPaldNU3hBT1R5d2czSHNLT0FsSWZvVjluWmZOQlB4QmJ0eTZVRDhhWFhhSjdQSWR6b2lVVGhBODVicURZMHZnOFk5RVBmUGhtMDNqRnBjODMxc0U2LVc1NTlMNHM1VGlaT0E?oc=5", "source_name": "Kalkine", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mayne Pharma Group H1 2026 Loss Narrowing Tests Bearish Narratives On Profitability Path", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mayne Pharma to return to court to fight Cosette for failed bid costs", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxQUUl4SkE0UEg3SFJyVlVMcWRMUjFpTENPLXUwajYtc0hYWnN2ZW1qWDgwX2FyUFp2MEFWUi1XQUZnUW4yRHRMeHl2UE1fU0pVNEd2SmJ6WHlFUEtDR3RNc1NkcE9vc195bUJTeURQVlNmUVY0T3ZxVHVBQ0ZOcURsZ09TSHFUVUhSdndFWHdPYTRLUEFBR2tocG5mdTlGSUZCUWFPdHRBZHFjeXdqV0dvWHEyUGhGNFdxTW5YektDNHdYSFphbzFIUl9wQWlMVy02cXlmcw?oc=5", "source_name": "AFR", "published_at": "2026-01-29T08:00:00+00:00", "published_display": "29 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mayne Pharma weighs sale of US operations to unlock shareholder value", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxOR3Rwc2xRaG1NRW5nSmVOeHQwTDJjYXFjYjhlZzB1UVNYM1h2VTY2ZG9TSjZIamEyUk5waWJ2RFkwNGRmdDJ5YVctZ3Q5VUZsOExObERCRVl5TEJmeV9obGFMYjFlZ05aSTcwd0hYc0pxd3V2bHl2T3dvNlhlMkYwQjdsdVBCZjJDRFBBQ2ZTRnFhS19CY3lCZ203dW5hMVhGQ0JWN2NqRGtSQ1pYYnBlaUxrREN0NUtTRHozVWs5WW9DcURDdzdxaS1zUFlBNWVidGYwLURQZU10Y2xHNFNYcEtBbw?oc=5", "source_name": "Capital Brief", "published_at": "2026-01-19T08:00:00+00:00", "published_display": "19 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mayne Pharma under earnings pressure after failed takeover deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNM2lYX0ZCdFVIZjJNTjdscXFQT3ZwTElMY21pMjIyRGtOa2lKWkdDTjFHVHFLbU1BRmRzejhmYVZGNDZZekhWRnptSWdFdk8ySF9IUGhPZW11SC1oM2tPb3pZOUVZejZ0UjViekRiVVVwaFhraFdJbmNIZEgxQnRGTW5QbmxaWnVCbTBXMllCWE96ZUFHUm5VSU5mQ09aTURXRTRsUWpZblZmNG5iVy1jRzR5MFBidXlZbVhhbU16WmtaMUxlaXNpdDFBdlA?oc=5", "source_name": "AFR", "published_at": "2025-12-22T08:00:00+00:00", "published_display": "22 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Australian government rejects Cosette's proposed Mayne Pharma buyout, citing 'national interest'", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOanR5UEttMWNYeklEZU13TWFYUXRnc05oUEpVQWRvRXY3ZmROS2lCVXhvblpqVnVwWEZyS0t2NUZsNEV0S0U3dVhRVFBJbE5tdGF3aHdKY3pZelFFTElnNW5SY0Y4ZlVReFkydXFGd25YZlNJblV5aUVQdFUxbDdmNTdpbUNwRlJGalBFaHI5dHJ1cHhxU1EtRmJQekcxTHcwUmJmYzdDU3FDeU4tMU5YQ282NldyTEF4bjdhUzRFTlM1VGFfWVdZ?oc=5", "source_name": "Fierce Pharma", "published_at": "2025-11-21T08:00:00+00:00", "published_display": "21 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chalmers kills $672m Mayne takeover on national interest grounds", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPQ0cxUDd5ZEVUczJjaHRDSmdkakxfNkhEZW5kVkpmYndHY0RfcnQxRDRwa1F1QXRfaFc1M0lxbUMzS081TXRvWmFORGIwN3ZoZ2VEcDNEUkZzaUw1cDVJc2RadXllbjFlMjlmZ2JXdFRSUUplZkNVaEpDNlBPN2FwTUxuRlJqN0Y0dVEydHNsai1Gcm9PU25HX0h5WDN3bV9hMk5SaEtPV2hGYmpzcFd4U0FrdDVNeDhTYjBtX2RJQWhIaUk0Vkpnd1BfN18?oc=5", "source_name": "AFR", "published_at": "2025-11-21T08:00:00+00:00", "published_display": "21 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mayne Pharma shares surge on Takeovers Panel's ruling", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxON3JiT2c1T2EzX3hzeVA2WV80YjZ3ZDRaNUFkQzhlSkJPRGUxOUs2R1l6aUF5MklKLUduSUZvNk80TUpJZDRqZmYtOHNScVFLMHNfcXJxNmpKLUllaUdZY1BkUlZpM0hBbldkWjc5THZVOE5HTU03bEpJZjJKdzJsLTdEVDFESS02dkE1MGwtQUFhTm05M05uV1c2akd0VnJ1TlNVSjV2Zk1wYm4zT0FqVmJKY3dnd3VuN0VGYXFJdGRQWVM5bUE?oc=5", "source_name": "Proactive financial news", "published_at": "2025-11-20T08:00:00+00:00", "published_display": "20 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Australia Blocks U.S.-Based Cosette\u2019s $387.2 Million Takeover of Mayne Pharma", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNODI3QXp3UDFDcG9PNnZtd3NUazFGdEZyNVd3MEpfNy1CZkxXeE1zV0xpQ3JVd2xLYlJzcjVUQlJsaWlvT0pVVk9fcllDS3FyNVVMSDU3Qmd0ckdaQTNrRlNoUjYtUUJlckV4RHp2Z3VOTzlvNlBVbVNaVkluYjFfNW82NXlFUHMtcnRTWmEyTjFCU1ZrUzBNbUdjUlFxNV9uWmdXOWkzU3BRQkdnUWlNeE4tZFVFRDY5NGc?oc=5", "source_name": "WSJ", "published_at": "2025-11-20T08:00:00+00:00", "published_display": "20 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Australian Shares Fall; Australia Blocks Cosette's Proposed Mayne Pharma Acquisition on National Interest Grounds", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPeW1EY0FHb213X3NHM3RtNG0wOHB1Q2ktNzN4WEVfUjk1bDVtMnBVUGlqVGQ3UjctbHlIaGV4QmlRM3NDMlZzbGFlZmxlRXZQYnJXUWVEYTB3TUpweDdka0xPeHFYTjF1NWRiT2JFWm91aWNpeExsT3JZTHRNMzFMeFQyeVZDZUJqLXlFTE9nNUczUQ?oc=5", "source_name": "Market source", "published_at": "2025-11-20T08:00:00+00:00", "published_display": "20 Nov 2025 08:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treasurer\u2019s intervention likely to trigger Mayne Pharma break-up", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2025-11-03T08:00:00+00:00", "published_display": "03 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mayne Pharma Collapses 30% as Treasurer Flags National-Interest Block in Cosette Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE04WVpTWUdtSjRJVjlVU1NuY3NOMDZ1ZXFzcWcwZjAtc0NZRlpadEtnUmVhY2FCZ0t0VXVfZVBYMGlzQWlzSnl4VTExQ2Y0b3pISDdR?oc=5", "source_name": "Stocks Down Under", "published_at": "2025-10-31T07:00:00+00:00", "published_display": "31 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Court blocks Cosette's attempt to drop $438 million Mayne deal; shares jump", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxOOTh0emdNRUVtemhydllJWEhtQkxSUUdCa05BeGFBR3dCc0w5XzFVYjVQd2xVcWpYeE5PeVdDb01wY1U2THdTYWFndjJVd3c5eDloelFCMVotbi0tR0dMT2xwOVNwWWF0Q3FwTW9MRnlZVXFOMm9odkdZYW5MLVo1MGppcFZoSlZMNjBVRlFHRFNjYVkzR3ZRRlppNGt3bEdUN0hNZFF3M21raXBzUkozY2VFZndzNk1SSmdkUUJoVkVsOXpoNUZLSnF6XzBfakZJQnZCeHRn?oc=5", "source_name": "Reuters", "published_at": "2025-10-15T07:00:00+00:00", "published_display": "15 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How the fight over $672m pharma deal became a 'watershed' moment for ASX takeovers", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxQYUE2NGd1d2NYaXJGVTIzRDFpTHpvcE1vZXFGUFJIQ29jNUlseEJvcF9uT2ZpbDY4ZXBTT2E4OGEzWkREWUZ1ZzRxR2FXLWR3VWxyMF9UMDZCaGNkczVVbUhGLUJKM2pEY0NMc0dma015a2trRGd1R0JKbHQ3ekczWkROTmM3b1pfR1BrOVZIRWt3c2ViLUFOZ3V1SlRtUTdNUERIeTJpYThLa19RbENmbXZHVElia2pTTWQzZzIwbk83QkpWcjI2UDAyaGFQd3VMdzdwREpKVUttNFRYd2xlQmdyRG00aVFZYUE?oc=5", "source_name": "Capital Brief", "published_at": "2025-09-22T07:00:00+00:00", "published_display": "22 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inside Mayne Pharma suitor\u2019s battle to sink Project Crocodile", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxQLWpNTXJsOWJHWmYtTGhhak9yM2gzUFFxNFhNaFd2ckFzNkFjRlJwc3NWRC15cFpDdnBqaklIWFFDSVhHTkxKaFRoYzd4ZWQwVXhLS0l0QkJWMXRBbDVGR0N2UEQyRDZzbjdfNmUtcWxwUDdnaGFvOWR4Zm5Qdm5VeFpoZ00wR1h4UEw1MnRxTjFsMHpIcnl6T3NDZmNhTFZ4Qjd3SUozQjlfS2lDU1U4MExCQlpaUHlEblhCS0hsdTZrLTdiNW52NmxR?oc=5", "source_name": "AFR", "published_at": "2025-09-19T07:00:00+00:00", "published_display": "19 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Mayne Pharma Group (ASX:MYX) Rises 3.55%: What's Behind the Pharma Stock's Move?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOS1lwRG92YVp3cEx1cHBWbkZnc1E4emVPaTBfUFFNRnRQR3Joc0lDSkp6cGFqeFhha2ZMSE5GbU13bnVOYnhGRHhvWHRMRWc4RXNLZjhvMnB3V0U2S1pVd2xHT2FXNzczWGczZy1zeDZTd1BKWklQQ2pmbXUydWJVR1BsaDVuY2JWYTJDMHlKcldfMlRMOTlzNDl6ZHVpR3h5UzdLYVpyQ0F4X25hTGxz?oc=5", "source_name": "Kalkine", "published_at": "2026-07-16T10:30:00+00:00", "published_display": "16 Jul 2026 10:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Private equity kicked the tyres at Mayne\u2019s Adelaide plant, but no dice", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOa1RjZnZ5VkxvQ2FydmVkMVVFSEdFOUtfUUFTWkktdUZQeUxzQlpiMkR1YWl6bEJqNXlIUm1aYllYMUlVRHlyWWVqcm5zbjR3b0Z2b2JYMlJyV0lSV0JOcVpiTHdNSVFqZ2xHckNVSkVSM2pjTVp2dmdKdlNXR1FNemlWSmYyTE93NzZMdmRHX3JQZmlaOFFFRG1qblBaRlVlN05CbnpReHdneXdpNkVLdGVQbXM3UHVD?oc=5", "source_name": "AFR", "published_at": "2026-07-12T05:36:00+00:00", "published_display": "12 Jul 2026 05:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What\u2019s Driving Fresh Interest in Mayne Pharma (ASX:MYX) Shares?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPbVk4ZWtSZVFsWHlRaFFRZ3JKem0zY1U1OGxoQXlERXRLeHA3V01kRm1LVkxaUXB5WldrUmU1Sm80QnRiN3hyUng3cEQ0Q2JSUm1RZTM1N1ZuMVZlcktpZG1HRzY5MWx0QkkteWNELXJLaDc2bk00bTdKWHlYRVQ3dmpEaXpNWTZtM1JJUWZoUFA3WDg2MEdHclZIR1Bvdw?oc=5", "source_name": "Kalkine", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New South Wales Supreme Court Awards Mayne Pharma Group Over AU$13 Million in Legal Costs Following Cosette Pharmaceuticals Proceedings; Shares Up 6%", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxObXlKT1J0czBjYjZ6cE43UEJQQ3ZpYVpkSmlxZTlGUFZEUlN2NFNHWU1QMWVoel9pVzB4S3dNU1pIajlIaFZDQmdxcDZlWWk2MUlUWHlNVXpzdHNrZnZGZXBvTDYwTlQybm5IVTd5N1ZxM3pybVROMzY4M0lxMnNaeXJaWlByTk1oM3pYTHpuQ3dOTDM2R0toZDlEVUItdWI2enNnUQ?oc=5", "source_name": "Moomoo", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mayne Pharma Group (ASX:MYX) Shares Under Pressure as Deep Losses Continue to Weigh on Sentiment", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOa2JFOVZfa2pNLWs1c1E5VWtaNjBfNHVpLUIyblN4UU9veHdPR04zb0wwQTBEVzVUNVFTREk0WHZRMENDbzV4YkxaN2Rab2N0UlFDeWFkRk0zNlFfQVlITFdycmdDU194X0NWb2xsTkMwVVpCLThpTGxjdHp0YWtEMzRTZTVvc28zaXVRSmJ4ZDdCd1Z2Ykh6UlBrTlBrNVRUUlQ2Q3BoWExzaGpRc3Fhdk1Cc3FRaWtXWWUyR0tyenU5MGFhRnZneFRyc0Y?oc=5", "source_name": "Kalkine", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Health Check: We will duck Donald\u2019s tariffs, say CSL and Mayne Pharma", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPZEN0SHNMcnBMemRGUk5Jb2RGa1JUNEtxeTE5RXIySlYxd3B2Q1hqOGtCbE5tbnJjV3p2bDZMeUtIbmFjLThzNXQyd2dwZXB6Njh0cW11dmJ3SnVNYV9HWHZIVTh2clBmX3JZdGdobHc5dGhJa1JjVjlCeGxUWHR2Z01tVVZodFFmZUx0a1ZWT2NmakJ4R0pUaE9pdnJrcmJvUUE?oc=5", "source_name": "Stockhead", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mayne Pharma Group (ASX:MYX) Faces Selling Pressure: What to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxORERFMElIUF9ISTg1bWJaOVBLYmpucTdvVDRYWllSbThsWUpXYVBZazRZSURaTFJFbW1KVkNJbXdPaldNU3hBT1R5d2czSHNLT0FsSWZvVjluWmZOQlB4QmJ0eTZVRDhhWFhhSjdQSWR6b2lVVGhBODVicURZMHZnOFk5RVBmUGhtMDNqRnBjODMxc0U2LVc1NTlMNHM1VGlaT0E?oc=5", "source_name": "Kalkine", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mayne Pharma Group H1 2026 Loss Narrowing Tests Bearish Narratives On Profitability Path", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mayne Pharma to return to court to fight Cosette for failed bid costs", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxQUUl4SkE0UEg3SFJyVlVMcWRMUjFpTENPLXUwajYtc0hYWnN2ZW1qWDgwX2FyUFp2MEFWUi1XQUZnUW4yRHRMeHl2UE1fU0pVNEd2SmJ6WHlFUEtDR3RNc1NkcE9vc195bUJTeURQVlNmUVY0T3ZxVHVBQ0ZOcURsZ09TSHFUVUhSdndFWHdPYTRLUEFBR2tocG5mdTlGSUZCUWFPdHRBZHFjeXdqV0dvWHEyUGhGNFdxTW5YektDNHdYSFphbzFIUl9wQWlMVy02cXlmcw?oc=5", "source_name": "AFR", "published_at": "2026-01-29T08:00:00+00:00", "published_display": "29 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mayne Pharma weighs sale of US operations to unlock shareholder value", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxOR3Rwc2xRaG1NRW5nSmVOeHQwTDJjYXFjYjhlZzB1UVNYM1h2VTY2ZG9TSjZIamEyUk5waWJ2RFkwNGRmdDJ5YVctZ3Q5VUZsOExObERCRVl5TEJmeV9obGFMYjFlZ05aSTcwd0hYc0pxd3V2bHl2T3dvNlhlMkYwQjdsdVBCZjJDRFBBQ2ZTRnFhS19CY3lCZ203dW5hMVhGQ0JWN2NqRGtSQ1pYYnBlaUxrREN0NUtTRHozVWs5WW9DcURDdzdxaS1zUFlBNWVidGYwLURQZU10Y2xHNFNYcEtBbw?oc=5", "source_name": "Capital Brief", "published_at": "2026-01-19T08:00:00+00:00", "published_display": "19 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mayne Pharma under earnings pressure after failed takeover deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNM2lYX0ZCdFVIZjJNTjdscXFQT3ZwTElMY21pMjIyRGtOa2lKWkdDTjFHVHFLbU1BRmRzejhmYVZGNDZZekhWRnptSWdFdk8ySF9IUGhPZW11SC1oM2tPb3pZOUVZejZ0UjViekRiVVVwaFhraFdJbmNIZEgxQnRGTW5QbmxaWnVCbTBXMllCWE96ZUFHUm5VSU5mQ09aTURXRTRsUWpZblZmNG5iVy1jRzR5MFBidXlZbVhhbU16WmtaMUxlaXNpdDFBdlA?oc=5", "source_name": "AFR", "published_at": "2025-12-22T08:00:00+00:00", "published_display": "22 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Australian government rejects Cosette's proposed Mayne Pharma buyout, citing 'national interest'", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOanR5UEttMWNYeklEZU13TWFYUXRnc05oUEpVQWRvRXY3ZmROS2lCVXhvblpqVnVwWEZyS0t2NUZsNEV0S0U3dVhRVFBJbE5tdGF3aHdKY3pZelFFTElnNW5SY0Y4ZlVReFkydXFGd25YZlNJblV5aUVQdFUxbDdmNTdpbUNwRlJGalBFaHI5dHJ1cHhxU1EtRmJQekcxTHcwUmJmYzdDU3FDeU4tMU5YQ282NldyTEF4bjdhUzRFTlM1VGFfWVdZ?oc=5", "source_name": "Fierce Pharma", "published_at": "2025-11-21T08:00:00+00:00", "published_display": "21 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chalmers kills $672m Mayne takeover on national interest grounds", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPQ0cxUDd5ZEVUczJjaHRDSmdkakxfNkhEZW5kVkpmYndHY0RfcnQxRDRwa1F1QXRfaFc1M0lxbUMzS081TXRvWmFORGIwN3ZoZ2VEcDNEUkZzaUw1cDVJc2RadXllbjFlMjlmZ2JXdFRSUUplZkNVaEpDNlBPN2FwTUxuRlJqN0Y0dVEydHNsai1Gcm9PU25HX0h5WDN3bV9hMk5SaEtPV2hGYmpzcFd4U0FrdDVNeDhTYjBtX2RJQWhIaUk0Vkpnd1BfN18?oc=5", "source_name": "AFR", "published_at": "2025-11-21T08:00:00+00:00", "published_display": "21 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mayne Pharma shares surge on Takeovers Panel's ruling", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxON3JiT2c1T2EzX3hzeVA2WV80YjZ3ZDRaNUFkQzhlSkJPRGUxOUs2R1l6aUF5MklKLUduSUZvNk80TUpJZDRqZmYtOHNScVFLMHNfcXJxNmpKLUllaUdZY1BkUlZpM0hBbldkWjc5THZVOE5HTU03bEpJZjJKdzJsLTdEVDFESS02dkE1MGwtQUFhTm05M05uV1c2akd0VnJ1TlNVSjV2Zk1wYm4zT0FqVmJKY3dnd3VuN0VGYXFJdGRQWVM5bUE?oc=5", "source_name": "Proactive financial news", "published_at": "2025-11-20T08:00:00+00:00", "published_display": "20 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Australia Blocks U.S.-Based Cosette\u2019s $387.2 Million Takeover of Mayne Pharma", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNODI3QXp3UDFDcG9PNnZtd3NUazFGdEZyNVd3MEpfNy1CZkxXeE1zV0xpQ3JVd2xLYlJzcjVUQlJsaWlvT0pVVk9fcllDS3FyNVVMSDU3Qmd0ckdaQTNrRlNoUjYtUUJlckV4RHp2Z3VOTzlvNlBVbVNaVkluYjFfNW82NXlFUHMtcnRTWmEyTjFCU1ZrUzBNbUdjUlFxNV9uWmdXOWkzU3BRQkdnUWlNeE4tZFVFRDY5NGc?oc=5", "source_name": "WSJ", "published_at": "2025-11-20T08:00:00+00:00", "published_display": "20 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Australian Shares Fall; Australia Blocks Cosette's Proposed Mayne Pharma Acquisition on National Interest Grounds", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPeW1EY0FHb213X3NHM3RtNG0wOHB1Q2ktNzN4WEVfUjk1bDVtMnBVUGlqVGQ3UjctbHlIaGV4QmlRM3NDMlZzbGFlZmxlRXZQYnJXUWVEYTB3TUpweDdka0xPeHFYTjF1NWRiT2JFWm91aWNpeExsT3JZTHRNMzFMeFQyeVZDZUJqLXlFTE9nNUczUQ?oc=5", "source_name": "Market source", "published_at": "2025-11-20T08:00:00+00:00", "published_display": "20 Nov 2025 08:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treasurer\u2019s intervention likely to trigger Mayne Pharma break-up", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2025-11-03T08:00:00+00:00", "published_display": "03 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mayne Pharma Collapses 30% as Treasurer Flags National-Interest Block in Cosette Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE04WVpTWUdtSjRJVjlVU1NuY3NOMDZ1ZXFzcWcwZjAtc0NZRlpadEtnUmVhY2FCZ0t0VXVfZVBYMGlzQWlzSnl4VTExQ2Y0b3pISDdR?oc=5", "source_name": "Stocks Down Under", "published_at": "2025-10-31T07:00:00+00:00", "published_display": "31 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Court blocks Cosette's attempt to drop $438 million Mayne deal; shares jump", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxOOTh0emdNRUVtemhydllJWEhtQkxSUUdCa05BeGFBR3dCc0w5XzFVYjVQd2xVcWpYeE5PeVdDb01wY1U2THdTYWFndjJVd3c5eDloelFCMVotbi0tR0dMT2xwOVNwWWF0Q3FwTW9MRnlZVXFOMm9odkdZYW5MLVo1MGppcFZoSlZMNjBVRlFHRFNjYVkzR3ZRRlppNGt3bEdUN0hNZFF3M21raXBzUkozY2VFZndzNk1SSmdkUUJoVkVsOXpoNUZLSnF6XzBfakZJQnZCeHRn?oc=5", "source_name": "Reuters", "published_at": "2025-10-15T07:00:00+00:00", "published_display": "15 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How the fight over $672m pharma deal became a 'watershed' moment for ASX takeovers", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxQYUE2NGd1d2NYaXJGVTIzRDFpTHpvcE1vZXFGUFJIQ29jNUlseEJvcF9uT2ZpbDY4ZXBTT2E4OGEzWkREWUZ1ZzRxR2FXLWR3VWxyMF9UMDZCaGNkczVVbUhGLUJKM2pEY0NMc0dma015a2trRGd1R0JKbHQ3ekczWkROTmM3b1pfR1BrOVZIRWt3c2ViLUFOZ3V1SlRtUTdNUERIeTJpYThLa19RbENmbXZHVElia2pTTWQzZzIwbk83QkpWcjI2UDAyaGFQd3VMdzdwREpKVUttNFRYd2xlQmdyRG00aVFZYUE?oc=5", "source_name": "Capital Brief", "published_at": "2025-09-22T07:00:00+00:00", "published_display": "22 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inside Mayne Pharma suitor\u2019s battle to sink Project Crocodile", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxQLWpNTXJsOWJHWmYtTGhhak9yM2gzUFFxNFhNaFd2ckFzNkFjRlJwc3NWRC15cFpDdnBqaklIWFFDSVhHTkxKaFRoYzd4ZWQwVXhLS0l0QkJWMXRBbDVGR0N2UEQyRDZzbjdfNmUtcWxwUDdnaGFvOWR4Zm5Qdm5VeFpoZ00wR1h4UEw1MnRxTjFsMHpIcnl6T3NDZmNhTFZ4Qjd3SUozQjlfS2lDU1U4MExCQlpaUHlEblhCS0hsdTZrLTdiNW52NmxR?oc=5", "source_name": "AFR", "published_at": "2025-09-19T07:00:00+00:00", "published_display": "19 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 85, "total_relevant": 21, "sentiment_summary": {"positive": 1, "negative": 3, "neutral": 17, "score": 48, "total": 21, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 86, "events": [{"event": "general", "label": "Market update", "weight": 9.15, "count": 16}, {"event": "deals", "label": "Deals and strategy", "weight": 2.55, "count": 4}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 2.87, "latest_week": "2026-07-10", "one_week_move": 4.0, "four_week_move": 19.1, "twelve_week_move": 14.3, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 1.108043, "market_dynamics_buy_signal": false, "relative_strength": -20.06257, "fair_value_gap": -38.9, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 50.0, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+4.0% over one week, +19.1% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "AFR", "count": 5}, {"label": "Kalkine", "count": 4}, {"label": "Capital Brief", "count": 2}, {"label": "Moomoo", "count": 1}, {"label": "Stockhead", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "Fierce Pharma", "count": 1}, {"label": "Proactive financial news", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 21}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 16}, {"label": "Deals and strategy", "count": 4}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "48/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "86/100 classification confidence."}, {"label": "Company focus", "value": "21", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+4.0% over one week, +19.1% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Mayne Pharma Group (ASX:MYX) Rises 3.55%: What's Behind the Pharma Stock's Move?"}], "updated_at": "2026-07-17T06:19:22.734102+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}